Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
Nov 19, 2026, 13:36

Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy

Raja Prince, Founder and BOD of BLEEDnFIRE Therapeutics, shared BLEEDnFIRE Therapeutics‘ post on LinkedIn:

“Excited to present our latest research on Protein S silencing in FXI deficiency, von Willebrand disease and hemophilic arthropathies, together with Rim Diab and Siavash Rahimi at SOHC 2026!

Proud to share this moment highlighting our collective efforts to advance innovative therapies for bleeding disorders.

Looking forward to inspiring discussions!”

BLEEDnFIRE Therapeutics shared a post on LinkedIn:

“On Wednesday, November 18, the team will present three studies on Protein S at the Swiss Oncology and Hematology Congress (SOHC) in Basel.

Rim Diab will present research on controlled Protein S expression as a strategy to rebalance haemostasis in factor XI deficiency.

Raja Prince will present research on using siRNA to modulate Protein S expression and rebalance haemostasis in von Willebrand disease.

Siavash Rahimi will present findings on how Protein S modulates synovial and myeloid responses in haemophilic arthropathy.

Congratulations to all three speakers on being selected for oral presentations.

Come join us on Wednesday, 18 November, at 10:30 in Kairo 1–2, Congress Center Basel.”

Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy

Stay updated with Hemostasis Today.